VKTX: Multiplikator Forward P/S Viking Therapeutics Corp

Lambang korporat lan logo Viking Pharma (VKTX)

The forward revenue multiple for Viking Therapeutics (VKTX) is showing rapid growth, with the current level standing at . This trend reflects the creation of a protected ecosystem of anti-obesity drugs featuring the VK2735 molecule. Clinical trial successes and the probability of a corporate merger support the upside potential of the share price. However, the capital intensity of final testing and strict FDA oversight limit the entry of new participants into this sector.

Viking Therapeutics, Inc. - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep VKTX (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan vikingtherapeutics.com (VKTX)

Pambiji fundamental:vikingtherapeutics.com VKTX
Sampel barang Viking Therapeutics

Viking Therapeutics (VKTX) development of highly effective diabetes and obesity drugs makes the company an attractive acquisition target for pharmaceutical behemoths. By analyzing the expected price-to-sales ratio, an investor assesses current capitalization through the lens of future cash flows, which allows for the distinction between a fundamental trend reversal and speculative noise driven by capital inflows on this chart.

Analisis pesaing

Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|SUPN (Supernus Pharma) - Multiplikator Forward P/S|CPRX: Rega forward marang dodolan|Multiplikator Forward P/S DNLI|Rasio kapitalisasi marang dodolan sing dikarepake Harmony Biosciences|Biohaven Ltd - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Praxis Corp PRAX|AVXL: Multiplikator Forward P/S|CBLL (ceribell.com) - Rasio rega marang prakiraan pendapatan|PRTA (Prothena Corporation) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan alector.com (ALEC)|Rasio rega marang prakiraan pendapatan Annexon, Inc. (ANNX)|OMER - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Voyager Therapeutics Inc - Multiplikator Forward P/S|Neumora (NMRA) - Multiplikator forward rega marang pendapatan|SCLX: Multiplikator Forward P/S|TVGN - Rasio kapitalisasi marang dodolan sing dikarepake|ACOG (Alpha Cognition Inc) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan cogrx.com (CGTX)|Rasio rega marang prakiraan pendapatan Inhibikase Therapeutics Inc (IKT)|Rasio kapitalisasi marang dodolan sing dikarepake Cassava Sciences|Multiplikator Forward P/S ASRT (Assertio Holdings)|COYA - Multiplikator forward rega marang pendapatan|vistagen.com - Multiplikator Forward P/S|OVID: Rasio rega marang prakiraan pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang prakiraan pendapatan|CervoMed Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PEPG (PepGen Inc)|Multiplikator Forward P/S jupiterneurosciences.com (JUNS)|Rasio rega marang prakiraan pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalisasi marang prakiraan pendapatan|Grace Tx - Multiplikator Forward P/S|AIFF (Firefly Neuroscience Inc) - Kapitalisasi marang prakiraan pendapatan|KLTO: Multiplikator Forward P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Reviva Pharmaceuticals, Inc.|Multiplikator forward rega marang pendapatan metaviatx.com (MTVA)|Multiplikator Forward P/S NRXS|HSDT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Passage Bio, Inc. - Multiplikator forward rega marang pendapatan|bionomics.com.au (NEUP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Minerva - Multiplikator Forward P/S|Rega forward marang dodolan ATHA (Athira Pharma Inc)|ADXN: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|PTIX (Protagenic Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|Rasio kapitalisasi marang dodolan sing dikarepake Cortigent|Multiplikator Forward P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|Cara Therapeutics Inc. - Multiplikator Forward P/S|Chromocell Therapeutics (CHRO) - Multiplikator forward rega marang pendapatan|ELYM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator Forward P/S|Marinus - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S